Structure

InChI Key GQPYTJVDPQTBQC-KLQYNRQASA-N
Smile N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O
InChI
InChI=1S/C16H15F6N5O.H3O4P.H2O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-5(2,3)4;/h4,6,9H,1-3,5,7,23H2;(H3,1,2,3,4);1H2/t9-;;/m1../s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C16H20F6N5O6P
Molecular Weight 523.33
AlogP 2.02
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 77.04
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Dipeptidyl peptidase IV inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus 1 D003920 ClinicalTrials
Renal Insufficiency 1 D051437 ClinicalTrials

Related Entries

Parent
Mixture
Mixture
Mixture
Mixture
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
14.5
General disorders and administration site conditions
7.71
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
6.91
Metabolism and nutrition disorders
6.11
Vascular disorders
5.84
Respiratory, thoracic and mediastinal disorders
5.4
Investigations
5.36
Nervous system disorders
5.33
Musculoskeletal and connective tissue disorders
4.87
Surgical and medical procedures
4.73
Cardiac disorders
4.54
Hepatobiliary disorders
3.46
Skin and subcutaneous tissue disorders
3.33
Renal and urinary disorders
3.31
Injury, poisoning and procedural complications
3.05
Endocrine disorders
2.99
Psychiatric disorders
2.89
Infections and infestations
2.72
Blood and lymphatic system disorders
2.21

Cross References

Resources Reference
ChEMBL CHEMBL1201174
FDA SRS TS63EW8X6F
PubChem 11591741
SureChEMBL SCHEMBL1039535